endocarditis
发表于 2025-3-21 18:16:18
书目名称Managing Gout in Primary Care影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0623041<br><br> <br><br>书目名称Managing Gout in Primary Care读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0623041<br><br> <br><br>
BOOM
发表于 2025-3-21 21:39:38
Treatment of Hyperuricemia in Gout,reducing the risk of episodes of acute inflammation (EAIs) that appear and even increase in frequency during the initiation of ULT (prophylaxis); (3) promptly, safely, and effectively treating any EAIs that may appear until proper and stable serum urate levels are achieved.
幸福愉悦感
发表于 2025-3-22 03:24:33
http://reply.papertrans.cn/63/6231/623041/623041_3.png
orthopedist
发表于 2025-3-22 07:18:40
Physiopathology of gout,nd genetic or acquired tissue predisposition for the nucleation of MSUCs, may explain why not all patients with hyperuricemia develop gout, or why some patients develop early or rapidly progressive symptoms associated with gout.
Credence
发表于 2025-3-22 10:49:25
http://reply.papertrans.cn/63/6231/623041/623041_5.png
daredevil
发表于 2025-3-22 13:59:10
Book 2014ood-quality evidence on gout impact and management has grown exponentially, renal transporters have been recently identified, and a number of new drugs have been approved or are under current development.
异端邪说2
发表于 2025-3-22 20:03:02
http://reply.papertrans.cn/63/6231/623041/623041_7.png
无目标
发表于 2025-3-22 22:32:38
Physiopathology of gout,vial fluid or cause aggregate-inducing chronic tissue inflammation. The nucleation and formation of MSUCs is related to the presence of longstanding hyperuricemia, which is an essential factor in the development of gout. Other factors, such as level of hyperuricemia, time exposed to hyperuricemia, a
BLOT
发表于 2025-3-23 05:03:16
http://reply.papertrans.cn/63/6231/623041/623041_9.png
迅速成长
发表于 2025-3-23 09:36:10
Treatment of Hyperuricemia in Gout,urate to the therapeutic range to dissolve monosodium urate crystals (MSUCs) formed in tissues, using urate-lowering therapy (ULT); (2) preventing or reducing the risk of episodes of acute inflammation (EAIs) that appear and even increase in frequency during the initiation of ULT (prophylaxis); (3)